Mogford, J E <br/><br/>
RGDN peptide interaction with endothelial alpha5beta1 integrin causes sustained endothelin-dependent vasoconstriction of rat skeletal muscle arterioles.  [electronic resource] 

 -  The Journal of clinical investigation  Sep 1997 
 - 1647-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI119689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Blocking--pharmacology<br/>Antigens, CD--immunology<br/>Arterioles--drug effects<br/>Dose-Response Relationship, Drug<br/>Endothelin Receptor Antagonists<br/>Endothelium, Vascular--drug effects<br/>Fibronectins--pharmacology<br/>In Vitro Techniques<br/>Integrin alpha5<br/>Integrin beta3<br/>Male<br/>Muscle, Skeletal--blood supply<br/>Oligopeptides--pharmacology<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Platelet Membrane Glycoproteins--immunology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Endothelin A<br/>Receptors, Fibronectin--physiology<br/>Receptors, Vitronectin--physiology<br/>Time Factors<br/>Vasoconstriction--physiology